-
1
-
-
84864477617
-
Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
-
The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803-869. doi: 10.1093/eurjhf/hfs105.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Böhm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
Jaarsma, T.11
Køber, L.12
Lip, G.Y.13
Maggioni, A.P.14
Parkhomenko, A.15
Pieske, B.M.16
Popescu, B.A.17
Rønnevik, P.K.18
Rutten, F.H.19
Schwitter, J.20
Seferovic, P.21
Stepinska, J.22
Trindade, P.T.23
Voors, A.A.24
Zannad, F.25
Zeiher, A.26
Bax, J.J.27
Baumgartner, H.28
Ceconi, C.29
Dean, V.30
Deaton, C.31
Fagard, R.32
Funck-Brentano, C.33
Hasdai, D.34
Hoes, A.35
Kirchhof, P.36
Knuuti, J.37
Kolh, P.38
McDonagh, T.39
Moulin, C.40
Popescu, B.A.41
Reiner, Z.42
Sechtem, U.43
Sirnes, P.A.44
Tendera, M.45
Torbicki, A.46
Vahanian, A.47
Windecker, S.48
McDonagh, T.49
Sechtem, U.50
Bonet, L.A.51
Avraamides, P.52
Ben Lamin, H.A.53
Brignole, M.54
Coca, A.55
Cowburn, P.56
Dargie, H.57
Elliott, P.58
Flachskampf, F.A.59
Guida, G.F.60
Hardman, S.61
Iung, B.62
Merkely, B.63
Mueller, C.64
Nanas, J.N.65
Nielsen, O.W.66
Orn, S.67
Parissis, J.T.68
Ponikowski, P.69
more..
-
2
-
-
77649091020
-
Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association
-
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:948-954. doi: 10.1161/CIRCULATIONAHA.109.192666.
-
(2010)
Circulation
, vol.121
, pp. 948-954
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
Carnethon, M.4
Dai, S.5
De Simone, G.6
Ferguson, T.B.7
Ford, E.8
Furie, K.9
Gillespie, C.10
Go, A.11
Greenlund, K.12
Haase, N.13
Hailpern, S.14
Ho, P.M.15
Howard, V.16
Kissela, B.17
Kittner, S.18
Lackland, D.19
Lisabeth, L.20
Marelli, A.21
McDermott, M.M.22
Meigs, J.23
Mozaffarian, D.24
Mussolino, M.25
Nichol, G.26
Roger, V.L.27
Rosamond, W.28
Sacco, R.29
Sorlie, P.30
Stafford, R.31
Thom, T.32
Wasserthiel-Smoller, S.33
Wong, N.D.34
Wylie-Rosett, J.35
more..
-
3
-
-
40949086056
-
Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)
-
Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008;101:1016-1022. doi: 10.1016/j.amjcard.2007.11.061.
-
(2008)
Am J Cardiol
, vol.101
, pp. 1016-1022
-
-
Loehr, L.R.1
Rosamond, W.D.2
Chang, P.P.3
Folsom, A.R.4
Chambless, L.E.5
-
4
-
-
75549091095
-
Heart failure burden and therapy
-
Zannad F, Agrinier N, Alla F. Heart failure burden and therapy. Europace. 2009;11(suppl 5):v1-v9. doi: 10.1093/europace/eup304.
-
(2009)
Europace
, vol.11
, pp. v1-v9
-
-
Zannad, F.1
Agrinier, N.2
Alla, F.3
-
5
-
-
84980396108
-
Authors/ Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
-
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/ Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-2200. doi: 10.1093/eurheartj/ehw128.
-
(2016)
Eur Heart J
, vol.37
, pp. 2129-2200
-
-
Ponikowski, P.1
Voors, A.A.2
Anker, S.D.3
Bueno, H.4
Cleland, J.G.5
Coats, A.J.6
Falk, V.7
González-Juanatey, J.R.8
Harjola, V.P.9
Jankowska, E.A.10
Jessup, M.11
Linde, C.12
Nihoyannopoulos, P.13
Parissis, J.T.14
Pieske, B.15
Riley, J.P.16
Rosano, G.M.17
Ruilope, L.M.18
Ruschitzka, F.19
Rutten, F.H.20
Van Der Meer, P.21
more..
-
6
-
-
84969871823
-
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016;134:e282-e293. doi: 10.1161/CIR.0000000000000435.
-
(2016)
Circulation
, vol.134
, pp. e282-e293
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
Butler, J.4
Casey, D.E.5
Colvin, M.M.6
Drazner, M.H.7
Filippatos, G.8
Fonarow, G.C.9
Givertz, M.M.10
Hollenberg, S.M.11
Lindenfeld, J.12
Masoudi, F.A.13
McBride, P.E.14
Peterson, P.N.15
Stevenson, L.W.16
Westlake, C.17
-
7
-
-
84907087561
-
Angiotensin-neprilysin inhibition versus enalapril in heart failure
-
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGMHF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993-1004. doi: 10.1056/NEJMoa1409077.
-
(2014)
N Engl J Med
, vol.371
, pp. 993-1004
-
-
McMurray, J.J.1
Packer, M.2
Desai, A.S.3
Gong, J.4
Lefkowitz, M.P.5
Rizkala, A.R.6
Rouleau, J.L.7
Shi, V.C.8
Solomon, S.D.9
Swedberg, K.10
Zile, M.R.11
-
8
-
-
84879818084
-
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
-
Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 2013;11:159. doi: 10.1186/1741-7015-11-159.
-
(2013)
BMC Med
, vol.11
, pp. 159
-
-
Jansen, J.P.1
Naci, H.2
-
9
-
-
69949092149
-
Addressing between- study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation
-
Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ. Addressing between- study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med. 2009;28:1861-1881. doi: 10.1002/sim.3594.
-
(2009)
Stat Med
, vol.28
, pp. 1861-1881
-
-
Cooper, N.J.1
Sutton, A.J.2
Morris, D.3
Ades, A.E.4
Welton, N.J.5
-
10
-
-
84879740382
-
Evidence synthesis for decision making 2: A generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials
-
Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33:607-617. doi: 10.1177/0272989X12458724.
-
(2013)
Med Decis Making
, vol.33
, pp. 607-617
-
-
Dias, S.1
Sutton, A.J.2
Ades, A.E.3
Welton, N.J.4
-
11
-
-
79959925787
-
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
-
Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011;14:417-428. doi: 10.1016/j.jval.2011.04.002.
-
(2011)
Value Health
, vol.14
, pp. 417-428
-
-
Jansen, J.P.1
Fleurence, R.2
Devine, B.3
Itzler, R.4
Barrett, A.5
Hawkins, N.6
Lee, K.7
Boersma, C.8
Annemans, L.9
Cappelleri, J.C.10
-
12
-
-
84925548115
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012. doi: 10.1016/j. jclinepi.2009.06.005.
-
(2009)
J Clin Epidemiol
, vol.62
, pp. 1006-1012
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
13
-
-
70249117194
-
-
Layerthorpe, York, UK: Centre for Reviews and Dissemination, University of York
-
CRD's Guidance for Undertaking Reviews in Health Care. Layerthorpe, York, UK: Centre for Reviews and Dissemination, University of York; 2008.
-
(2008)
CRD's Guidance for Undertaking Reviews in Health Care
-
-
-
14
-
-
84903725920
-
A process for assessing the feasibility of a network meta-analysis: A case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
-
Cope S, Zhang J, Saletan S, Smiechowski B, Jansen JP, Schmid P. A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer. BMC Med. 2014;12:93. doi: 10.1186/1741-7015-12-93.
-
(2014)
BMC Med
, vol.12
, pp. 93
-
-
Cope, S.1
Zhang, J.2
Saletan, S.3
Smiechowski, B.4
Jansen, J.P.5
Schmid, P.6
-
15
-
-
26944454062
-
Simultaneous comparison of multiple treatments: Combining direct and indirect evidence
-
Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331:897-900. doi: 10.1136/bmj.331.7521.897.
-
(2005)
BMJ
, vol.331
, pp. 897-900
-
-
Caldwell, D.M.1
Ades, A.E.2
Higgins, J.P.3
-
16
-
-
52649100566
-
Bayesian meta-analysis of multiple treatment comparisons: An introduction to mixed treatment comparisons
-
Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008;11:956-964. doi: 10.1111/j.1524-4733.2008.00347.x.
-
(2008)
Value Health
, vol.11
, pp. 956-964
-
-
Jansen, J.P.1
Crawford, B.2
Bergman, G.3
Stam, W.4
-
17
-
-
5044221416
-
Combination of direct and indirect evidence in mixed treatment comparisons
-
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-3124. doi: 10.1002/ sim.1875.
-
(2004)
Stat Med
, vol.23
, pp. 3105-3124
-
-
Lu, G.1
Ades, A.E.2
-
18
-
-
0032938499
-
Systematic reviews and meta-analysis: A structured review of the methodological literature
-
Sutton AJ, Jones DR, Abrams KR, Sheldon TA, Song F. Systematic reviews and meta-analysis: a structured review of the methodological literature. J Health Serv Res Policy. 1999;4:49-55.
-
(1999)
J Health Serv Res Policy
, vol.4
, pp. 49-55
-
-
Sutton, A.J.1
Jones, D.R.2
Abrams, K.R.3
Sheldon, T.A.4
Song, F.5
-
20
-
-
70449411807
-
The BUGS project: Evolution, critique and future directions
-
Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, critique and future directions. Stat Med. 2009;28:3049-3067. doi: 10.1002/sim.3680.
-
(2009)
Stat Med
, vol.28
, pp. 3049-3067
-
-
Lunn, D.1
Spiegelhalter, D.2
Thomas, A.3
Best, N.4
-
21
-
-
0028886293
-
Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure
-
Widimský J, Kremer HJ, Jerie P, Uhlír O. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure. Eur J Clin Pharmacol. 1995;49:95-102.
-
(1995)
Eur J Clin Pharmacol
, vol.49
, pp. 95-102
-
-
Widimský, J.1
Kremer, H.J.2
Jerie, P.3
Uhlír, O.4
-
22
-
-
0023266532
-
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). the CONSENSUS Trial Study Group
-
Swedberg K. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-1435.
-
(1987)
N Engl J Med
, vol.316
, pp. 1429-1435
-
-
Swedberg, K.1
-
23
-
-
20644461232
-
Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group
-
Erhardt L, MacLean A, Ilgenfritz J, Gelperin K, Blumenthal M. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group. Eur Heart J. 1995;16:1892-1899.
-
(1995)
Eur Heart J
, vol.16
, pp. 1892-1899
-
-
Erhardt, L.1
MacLean, A.2
Ilgenfritz, J.3
Gelperin, K.4
Blumenthal, M.5
-
24
-
-
0027195253
-
Long-term survival in the Munich Mild Heart Failure Trial (MHFT)
-
Kleber FX, Niemöller L. Long-term survival in the Munich Mild Heart Failure Trial (MHFT). Am J Cardiol. 1993;71:1237-1239.
-
(1993)
Am J Cardiol
, vol.71
, pp. 1237-1239
-
-
Kleber, F.X.1
Niemöller, L.2
-
25
-
-
0026785561
-
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. the SOLVD Investigators
-
Yusuf S. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992;327:685-691.
-
(1992)
N Engl J Med
, vol.327
, pp. 685-691
-
-
Yusuf, S.1
-
26
-
-
0025913812
-
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
Yusuf S; The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302. doi: 10.1056/ NEJM199108013250501.
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
Yusuf, S.1
-
27
-
-
0029041919
-
Lisinopril versus placebo in the treatment of heart failure: The Lisinopril Heart Failure Study Group
-
Beller B, Bulle T, Bourge RC, Colfer H, Fowles RE, Giles TD, Grover J, Whipple JP, Fisher MB, Jessup M. Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group. J Clin Pharmacol. 1995;35:673-680.
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 673-680
-
-
Beller, B.1
Bulle, T.2
Bourge, R.C.3
Colfer, H.4
Fowles, R.E.5
Giles, T.D.6
Grover, J.7
Whipple, J.P.8
Fisher, M.B.9
Jessup, M.10
-
28
-
-
0028927869
-
Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group
-
Brown EJ Jr, Chew PH, MacLean A, Gelperin K, Ilgenfritz JP, Blumenthal M. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group. Am J Cardiol. 1995;75:596-600.
-
(1995)
Am J Cardiol
, vol.75
, pp. 596-600
-
-
Brown, E.J.1
Chew, P.H.2
MacLean, A.3
Gelperin, K.4
Ilgenfritz, J.P.5
Blumenthal, M.6
-
29
-
-
0023223741
-
Placebo-controlled study of lisinopril in congestive heart failure: A multicentre study
-
Chalmers JP, West MJ, Cyran J, De La Torre D, Englert M, Kramar M, Lewis GR, Maranhao MF, Myburgh DP, Schuster P. Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study. J Cardiovasc Pharmacol. 1987;9(suppl 3):S89-S97.
-
(1987)
J Cardiovasc Pharmacol
, vol.9
, pp. S89-S97
-
-
Chalmers, J.P.1
West, M.J.2
Cyran, J.3
De La Torre, D.4
Englert, M.5
Kramar, M.6
Lewis, G.R.7
Maranhao, M.F.8
Myburgh, D.P.9
Schuster, P.10
-
30
-
-
0026725794
-
Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. the Benazepril Heart Failure Study Group
-
Colfer HT, Ribner HS, Gradman A, Hughes CV, Kapoor A, Laidlaw JC. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group. Am J Cardiol. 1992;70:354-358.
-
(1992)
Am J Cardiol
, vol.70
, pp. 354-358
-
-
Colfer, H.T.1
Ribner, H.S.2
Gradman, A.3
Hughes, C.V.4
Kapoor, A.5
Laidlaw, J.C.6
-
31
-
-
0024294162
-
Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. the Captopril-Digoxin Multicenter Research Group
-
Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. JAMA. 1988;259:539-544.
-
(1988)
JAMA
, vol.259
, pp. 539-544
-
-
-
32
-
-
0024504450
-
Comparison of lisinopril versus placebo for congestive heart failure
-
Lewis GR. Comparison of lisinopril versus placebo for congestive heart failure. Am J Cardiol. 1989;63:12D-16D.
-
(1989)
Am J Cardiol
, vol.63
, pp. 12D-16D
-
-
Lewis, G.R.1
-
33
-
-
0032911302
-
Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure
-
Shettigar U, Hare T, Gelperin K, Ilgenfritz JP, Deitchman D, Blumenthal M. Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure. Congest Heart Fail. 1999;5:27-34.
-
(1999)
Congest Heart Fail
, vol.5
, pp. 27-34
-
-
Shettigar, U.1
Hare, T.2
Gelperin, K.3
Ilgenfritz, J.P.4
Deitchman, D.5
Blumenthal, M.6
-
34
-
-
0032420481
-
High- versus low-dose ACE inhibition in chronic heart failure: A double-blind, placebo-controlled study of imidapril
-
van Veldhuisen DJ, Genth-Zotz S, Brouwer J, Boomsma F, Netzer T, Man In 'T Veld AJ, Pinto YM, Lie KI, Crijns HJ. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril. J Am Coll Cardiol. 1998;32:1811-1818.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 1811-1818
-
-
Van Veldhuisen, D.J.1
Genth-Zotz, S.2
Brouwer, J.3
Boomsma, F.4
Netzer, T.5
Man In 'T Veld, A.J.6
Pinto, Y.M.7
Lie, K.I.8
Crijns, H.J.9
-
35
-
-
0034074905
-
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensinconverting enzyme inhibitors
-
Granger CB, Ertl G, Kuch J, Maggioni AP, McMurray J, Rouleau JL, Stevenson LW, Swedberg K, Young J, Yusuf S, Califf RM, Bart BA, Held P, Michelson EL, Sellers MA, Ohlin G, Sparapani R, Pfeffer MA. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensinconverting enzyme inhibitors. Am Heart J. 2000;139:609-617.
-
(2000)
Am Heart J
, vol.139
, pp. 609-617
-
-
Granger, C.B.1
Ertl, G.2
Kuch, J.3
Maggioni, A.P.4
McMurray, J.5
Rouleau, J.L.6
Stevenson, L.W.7
Swedberg, K.8
Young, J.9
Yusuf, S.10
Califf, R.M.11
Bart, B.A.12
Held, P.13
Michelson, E.L.14
Sellers, M.A.15
Ohlin, G.16
Sparapani, R.17
Pfeffer, M.A.18
-
36
-
-
0032727627
-
Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators
-
Riegger GA, Bouzo H, Petr P, Münz J, Spacek R, Pethig H, von Behren V, George M, Arens H. Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators. Circulation. 1999;100:2224-2230.
-
(1999)
Circulation
, vol.100
, pp. 2224-2230
-
-
Riegger, G.A.1
Bouzo, H.2
Petr, P.3
Münz, J.4
Spacek, R.5
Pethig, H.6
Von Behren, V.7
George, M.8
Arens, H.9
-
37
-
-
0037869441
-
Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure
-
Mitrovic V, Willenbrock R, Miric M, Seferovic P, Spinar J, Dabrowski M, Kiowski W, Marks DS, Alegria E, Dukát A, Lenz K, Arens HA. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure. Am Heart J. 2003;145:E14. doi: 10.1067/mhj.2003.161.
-
(2003)
Am Heart J
, vol.145
, pp. E14
-
-
Mitrovic, V.1
Willenbrock, R.2
Miric, M.3
Seferovic, P.4
Spinar, J.5
Dabrowski, M.6
Kiowski, W.7
Marks, D.S.8
Alegria, E.9
Dukát, A.10
Lenz, K.11
Arens, H.A.12
-
38
-
-
0030902115
-
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
-
Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
Meurers, G.4
Cowley, A.J.5
Thomas, I.6
Deedwania, P.C.7
Ney, D.E.8
Snavely, D.B.9
Chang, P.I.10
-
39
-
-
0034612118
-
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial-the Losartan Heart Failure Survival Study ELITE II
-
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582-1587.
-
(2000)
Lancet
, vol.355
, pp. 1582-1587
-
-
Pitt, B.1
Poole-Wilson, P.A.2
Segal, R.3
Martinez, F.A.4
Dickstein, K.5
Camm, A.J.6
Konstam, M.A.7
Riegger, G.8
Klinger, G.H.9
Neaton, J.10
Sharma, D.11
Thiyagarajan, B.12
-
40
-
-
0035131633
-
Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) Investigators. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. the Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) investigators
-
discussion 139
-
Dunselman PH; Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) Investigators. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) investigators. Int J Cardiol. 2001;77:131-138; discussion 139.
-
(2001)
Int J Cardiol
, vol.77
, pp. 131-138
-
-
Dunselman, P.H.1
-
41
-
-
0029102699
-
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
-
Dickstein K, Chang P, Willenheimer R, Haunsø S, Remes J, Hall C, Kjekshus J. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol. 1995;26:438-445.
-
(1995)
J Am Coll Cardiol
, vol.26
, pp. 438-445
-
-
Dickstein, K.1
Chang, P.2
Willenheimer, R.3
Haunsø, S.4
Remes, J.5
Hall, C.6
Kjekshus, J.7
-
42
-
-
0030881016
-
Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. the Losartan Pilot Exercise Study Investigators
-
Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. J Am Coll Cardiol. 1997;30:983-991.
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 983-991
-
-
Lang, R.M.1
Elkayam, U.2
Yellen, L.G.3
Krauss, D.4
McKelvie, R.S.5
Vaughan, D.E.6
Ney, D.E.7
Makris, L.8
Chang, P.I.9
-
43
-
-
0041909380
-
CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting- enzyme inhibitors: The CHARM-Alternative trial
-
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting- enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772-776. doi: 10.1016/S0140-6736(03)14284-5.
-
(2003)
Lancet
, vol.362
, pp. 772-776
-
-
Granger, C.B.1
McMurray, J.J.2
Yusuf, S.3
Held, P.4
Michelson, E.L.5
Olofsson, B.6
Ostergren, J.7
Pfeffer, M.A.8
Swedberg, K.9
-
44
-
-
0036773950
-
Heart Failure Valsartan Exercise Capacity Evaluation Study Group. Safety and efficacy of valsartan versus enalapril in heart failure patients
-
Willenheimer R, Helmers C, Pantev E, Rydberg E, Löfdahl P, Gordon A; Heart Failure Valsartan Exercise Capacity Evaluation Study Group. Safety and efficacy of valsartan versus enalapril in heart failure patients. Int J Cardiol. 2002;85:261-270.
-
(2002)
Int J Cardiol
, vol.85
, pp. 261-270
-
-
Willenheimer, R.1
Helmers, C.2
Pantev, E.3
Rydberg, E.4
Löfdahl, P.5
Gordon, A.6
-
45
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
-
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. doi: 10.1056/ NEJM199909023411001.
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
46
-
-
51349155508
-
Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III trial
-
Dobre D, van Veldhuisen DJ, Goulder MA, Krum H, Willenheimer R. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III trial. Cardiovasc Drugs Ther. 2008;22:399-405. doi: 10.1007/s10557-008-6116-9.
-
(2008)
Cardiovasc Drugs Ther
, vol.22
, pp. 399-405
-
-
Dobre, D.1
Van Veldhuisen, D.J.2
Goulder, M.A.3
Krum, H.4
Willenheimer, R.5
-
47
-
-
2942618618
-
Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF Evaluation)
-
Komajda M, Lutiger B, Madeira H, Thygesen K, Bobbio M, Hildebrandt P, Jaarsma W, Riegger G, Rydén L, Scherhag A, Soler-Soler J, Remme WJ; CARMEN Investigators and Co-Ordinators. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF Evaluation). Eur J Heart Fail. 2004;6:467-475. doi: 10.1016/j.ejheart.2003.12.019.
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 467-475
-
-
Komajda, M.1
Lutiger, B.2
Madeira, H.3
Thygesen, K.4
Bobbio, M.5
Hildebrandt, P.6
Jaarsma, W.7
Riegger, G.8
Rydén, L.9
Scherhag, A.10
Soler-Soler, J.11
Remme, W.J.12
-
48
-
-
0035818884
-
Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675. doi: 10.1056/ NEJMoa010713.
-
(2001)
N Engl J Med
, vol.345
, pp. 1667-1675
-
-
Cohn, J.N.1
Tognoni, G.2
-
49
-
-
0033514910
-
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
-
Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, Jondeau G, Olivari MT, Thomas S, Le Jemtel TH. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation. 1999;99:990-992.
-
(1999)
Circulation
, vol.99
, pp. 990-992
-
-
Hamroff, G.1
Katz, S.D.2
Mancini, D.3
Blaufarb, I.4
Bijou, R.5
Patel, R.6
Jondeau, G.7
Olivari, M.T.8
Thomas, S.9
Le Jemtel, T.H.10
-
50
-
-
0035978801
-
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
-
Eichhorn EJ. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
-
(2001)
N Engl J Med
, vol.344
, pp. 1659-1667
-
-
Eichhorn, E.J.1
-
51
-
-
0028092116
-
A randomized trial of beta-blockade in heart failure. the Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees
-
Lachat P. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation. 1994;90:1765-1773.
-
(1994)
Circulation
, vol.90
, pp. 1765-1773
-
-
Lachat, P.1
-
52
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
-
Lechat P. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
Lechat, P.1
-
53
-
-
0034660225
-
Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. the CELICARD Group
-
Witchitz S, Cohen-Solal A, Dartois N, Weisslinger N, Juste K, Darmon JY. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group. Am J Cardiol. 2000;85:1467-1471.
-
(2000)
Am J Cardiol
, vol.85
, pp. 1467-1471
-
-
Witchitz, S.1
Cohen-Solal, A.2
Dartois, N.3
Weisslinger, N.4
Juste, K.5
Darmon, J.Y.6
-
54
-
-
0037433183
-
Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: Results from the COPERNICUS Study
-
Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA. 2003;289:712-718.
-
(2003)
JAMA
, vol.289
, pp. 712-718
-
-
Krum, H.1
Roecker, E.B.2
Mohacsi, P.3
Rouleau, J.L.4
Tendera, M.5
Coats, A.J.6
Katus, H.A.7
Fowler, M.B.8
Packer, M.9
-
55
-
-
19544370840
-
Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: Results of the ENECA study
-
Edes I, Gasior Z, Wita K. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study. Eur J Heart Fail. 2005;7:631-639. doi: 10.1016/j.ejheart.2004.10.015.
-
(2005)
Eur J Heart Fail
, vol.7
, pp. 631-639
-
-
Edes, I.1
Gasior, Z.2
Wita, K.3
-
56
-
-
0033549290
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
-
Hjalmarson A. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
-
(1999)
Lancet
, vol.353
, pp. 2001-2007
-
-
Hjalmarson, A.1
-
57
-
-
0032757563
-
Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction
-
Goldstein S, Kennedy HL, Hall C, Anderson JL, Gheorghiade M, Gottlieb S, Jessup M, Karlsberg RP, Friday G, Haskell L. Metoprolol CR/XL in patients with heart failure: a pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction. Am Heart J. 1999;138(6 pt 1):1158-1165.
-
(1999)
Am Heart J
, vol.138
, Issue.6
, pp. 1158-1165
-
-
Goldstein, S.1
Kennedy, H.L.2
Hall, C.3
Anderson, J.L.4
Gheorghiade, M.5
Gottlieb, S.6
Jessup, M.7
Karlsberg, R.P.8
Friday, G.9
Haskell, L.10
-
58
-
-
0034044092
-
MIC trial: Metoprolol in patients with mild to moderate heart failure: Effects on ventricular function and cardiopulmonary exercise testing
-
Genth-Zotz S, Zotz RJ, Sigmund M, Hanrath P, Hartmann D, Böhm M, Waagstein F, Treese N, Meyer J, Darius H. MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing. Eur J Heart Fail. 2000;2:175-181.
-
(2000)
Eur J Heart Fail
, vol.2
, pp. 175-181
-
-
Genth-Zotz, S.1
Zotz, R.J.2
Sigmund, M.3
Hanrath, P.4
Hartmann, D.5
Böhm, M.6
Waagstein, F.7
Treese, N.8
Meyer, J.9
Darius, H.10
-
59
-
-
10544223267
-
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators
-
Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 1996;94:2807-2816.
-
(1996)
Circulation
, vol.94
, pp. 2807-2816
-
-
Bristow, M.R.1
Gilbert, E.M.2
Abraham, W.T.3
Adams, K.F.4
Fowler, M.B.5
Hershberger, R.E.6
Kubo, S.H.7
Narahara, K.A.8
Ingersoll, H.9
Krueger, S.10
Young, S.11
Shusterman, N.12
-
60
-
-
10544251442
-
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. the PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise
-
Packer M, Colucci WS, Sackner-Bernstein JD, Liang CS, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young ST, Lukas MA, Shusterman NH. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation. 1996;94:2793-2799.
-
(1996)
Circulation
, vol.94
, pp. 2793-2799
-
-
Packer, M.1
Colucci, W.S.2
Sackner-Bernstein, J.D.3
Liang, C.S.4
Goldscher, D.A.5
Freeman, I.6
Kukin, M.L.7
Kinhal, V.8
Udelson, J.E.9
Klapholz, M.10
Gottlieb, S.S.11
Pearle, D.12
Cody, R.J.13
Gregory, J.J.14
Kantrowitz, N.E.15
LeJemtel, T.H.16
Young, S.T.17
Lukas, M.A.18
Shusterman, N.H.19
-
61
-
-
2942527236
-
Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure
-
Cohen Solal A, Jondeau G, Beauvais F, Berdeaux A. Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure. Eur J Heart Fail. 2004;6:463-466. doi: 10.1016/j.ejheart.2003.12.007.
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 463-466
-
-
Cohen Solal, A.1
Jondeau, G.2
Beauvais, F.3
Berdeaux, A.4
-
62
-
-
0031230455
-
Safety and efficacy of carvedilol in severe heart failure. the U.S. Carvedilol Heart Failure Study Group
-
Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. J Card Fail. 1997;3:173-179.
-
(1997)
J Card Fail
, vol.3
, pp. 173-179
-
-
Cohn, J.N.1
Fowler, M.B.2
Bristow, M.R.3
Colucci, W.S.4
Gilbert, E.M.5
Kinhal, V.6
Krueger, S.K.7
Lejemtel, T.8
Narahara, K.A.9
Packer, M.10
Young, S.T.11
Holcslaw, T.L.12
Lukas, M.A.13
-
63
-
-
10544231452
-
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group
-
Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation. 1996;94:2800-2806.
-
(1996)
Circulation
, vol.94
, pp. 2800-2806
-
-
Colucci, W.S.1
Packer, M.2
Bristow, M.R.3
Gilbert, E.M.4
Cohn, J.N.5
Fowler, M.B.6
Krueger, S.K.7
Hershberger, R.8
Uretsky, B.F.9
Bowers, J.A.10
Sackner-Bernstein, J.D.11
Young, S.T.12
Holcslaw, T.L.13
Lukas, M.A.14
-
64
-
-
0009107171
-
Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure
-
de Milliano PA, de Groot AC, Tijssen JG, van Eck-Smit BL, Van Zwieten PA, Lie KI. Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure. Am Heart J. 2002;144:E3.
-
(2002)
Am Heart J
, vol.144
, pp. E3
-
-
De Milliano, P.A.1
De Groot, A.C.2
Tijssen, J.G.3
Van Eck-Smit, B.L.4
Van Zwieten, P.A.5
Lie, K.I.6
-
65
-
-
18744425643
-
Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: Analysis with magnetic resonance myocardial tagging
-
Dubach P, Myers J, Bonetti P, Schertler T, Froelicher V, Wagner D, Scheidegger M, Stuber M, Luchinger R, Schwitter J, Hess O. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging. Am Heart J. 2002;143:676-683.
-
(2002)
Am Heart J
, vol.143
, pp. 676-683
-
-
Dubach, P.1
Myers, J.2
Bonetti, P.3
Schertler, T.4
Froelicher, V.5
Wagner, D.6
Scheidegger, M.7
Stuber, M.8
Luchinger, R.9
Schwitter, J.10
Hess, O.11
-
66
-
-
0029085811
-
Double-blind, placebocontrolled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure
-
Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD. Double-blind, placebocontrolled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 1995;92:1499-1506.
-
(1995)
Circulation
, vol.92
, pp. 1499-1506
-
-
Krum, H.1
Sackner-Bernstein, J.D.2
Goldsmith, R.L.3
Kukin, M.L.4
Schwartz, B.5
Penn, J.6
Medina, N.7
Yushak, M.8
Horn, E.9
Katz, S.D.10
-
67
-
-
0029937949
-
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
-
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355. doi: 10.1056/ NEJM199605233342101.
-
(1996)
N Engl J Med
, vol.334
, pp. 1349-1355
-
-
Packer, M.1
Bristow, M.R.2
Cohn, J.N.3
Colucci, W.S.4
Fowler, M.B.5
Gilbert, E.M.6
Shusterman, N.H.7
-
68
-
-
19544374641
-
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure
-
Palazzuoli A, Quatrini I, Vecchiato L, Calabria P, Gennari L, Martini G, Nuti R. Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure. J Cardiovasc Pharmacol. 2005;45:563-568.
-
(2005)
J Cardiovasc Pharmacol
, vol.45
, pp. 563-568
-
-
Palazzuoli, A.1
Quatrini, I.2
Vecchiato, L.3
Calabria, P.4
Gennari, L.5
Martini, G.6
Nuti, R.7
-
69
-
-
27844583345
-
Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure
-
Palazzuoli A, Quatrini I, Vecchiato L, Scali C, De Paola V, Iovine F, Martini G, Nuti R. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure. Minerva Cardioangiol. 2005;53:321-328.
-
(2005)
Minerva Cardioangiol
, vol.53
, pp. 321-328
-
-
Palazzuoli, A.1
Quatrini, I.2
Vecchiato, L.3
Scali, C.4
De Paola, V.5
Iovine, F.6
Martini, G.7
Nuti, R.8
-
70
-
-
0034534141
-
Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril
-
Sturm B, Pacher R, Strametz-Juranek J, Berger R, Frey B, Stanek B. Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril. Eur J Heart Fail. 2000;2:407-412.
-
(2000)
Eur J Heart Fail
, vol.2
, pp. 407-412
-
-
Sturm, B.1
Pacher, R.2
Strametz-Juranek, J.3
Berger, R.4
Frey, B.5
Stanek, B.6
-
71
-
-
0141882923
-
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure
-
McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, Held P, Yusuf S. Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. Eur Heart J. 2003;24:1727-1734.
-
(2003)
Eur Heart J
, vol.24
, pp. 1727-1734
-
-
McKelvie, R.S.1
Rouleau, J.L.2
White, M.3
Afzal, R.4
Young, J.B.5
Maggioni, A.P.6
Held, P.7
Yusuf, S.8
-
72
-
-
0034142256
-
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: The randomized evaluation of strategies for left ventricular dysfunction pilot study
-
White M. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation. 2000;101:378-384.
-
(2000)
Circulation
, vol.101
, pp. 378-384
-
-
White, M.1
-
73
-
-
0041408235
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting- enzyme inhibitors: The CHARM-Added trial
-
McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting- enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767-771. doi: 10.1016/S0140-6736(03)14283-3.
-
(2003)
Lancet
, vol.362
, pp. 767-771
-
-
McMurray, J.J.1
Ostergren, J.2
Swedberg, K.3
Granger, C.B.4
Held, P.5
Michelson, E.L.6
Olofsson, B.7
Yusuf, S.8
Pfeffer, M.A.9
-
74
-
-
62449296975
-
AREA IN-CHF Investigators. Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): Final results
-
Boccanelli A, Mureddu GF, Cacciatore G, Clemenza F, Di Lenarda A, Gavazzi A, Porcu M, Latini R, Lucci D, Maggioni AP, Masson S, Vanasia M, de Simone G; AREA IN-CHF Investigators. Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail. 2009;11:68-76. doi: 10.1093/eurjhf/hfn015.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 68-76
-
-
Boccanelli, A.1
Mureddu, G.F.2
Cacciatore, G.3
Clemenza, F.4
Di Lenarda, A.5
Gavazzi, A.6
Porcu, M.7
Latini, R.8
Lucci, D.9
Maggioni, A.P.10
Masson, S.11
Vanasia, M.12
De Simone, G.13
-
75
-
-
78650399880
-
EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms
-
Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21. doi: 10.1056/NEJMoa1009492.
-
(2011)
N Engl J Med
, vol.364
, pp. 11-21
-
-
Zannad, F.1
McMurray, J.J.2
Krum, H.3
Van Veldhuisen, D.J.4
Swedberg, K.5
Shi, H.6
Vincent, J.7
Pocock, S.J.8
Pitt, B.9
-
76
-
-
0037125404
-
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
-
Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Marino P, Zardini P. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 2002;40:304-310.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 304-310
-
-
Cicoira, M.1
Zanolla, L.2
Rossi, A.3
Golia, G.4
Franceschini, L.5
Brighetti, G.6
Marino, P.7
Zardini, P.8
-
77
-
-
84897116317
-
Effects of spironolactone on long-term mortality and morbidity in patients with heart failure and mild or no symptoms
-
Vizzardi E, Nodari S, Caretta G, D'Aloia A, Pezzali N, Faden G, Lombardi C, Raddino R, Metra M, Dei Cas L. Effects of spironolactone on long-term mortality and morbidity in patients with heart failure and mild or no symptoms. Am J Med. Sci. 2014;347:271-276. doi: 10.1097/MAJ.0b013e31829dd6b1.
-
(2014)
Am J Med. Sci
, vol.347
, pp. 271-276
-
-
Vizzardi, E.1
Nodari, S.2
Caretta, G.3
D'Aloia, A.4
Pezzali, N.5
Faden, G.6
Lombardi, C.7
Raddino, R.8
Metra, M.9
Dei Cas, L.10
-
78
-
-
85026341952
-
The importance of treatment classifications that account for concomitant treatments in the context of a network meta-analysis comparing pharmacological treatments for chronic heart failure
-
Burnett H, Cope S, Vieira MC, Sagkriotis A, Senni M, Deschaseaux C. The importance of treatment classifications that account for concomitant treatments in the context of a network meta-analysis comparing pharmacological treatments for chronic heart failure. Value Health. 2014;17:A327. doi: 10.1016/j.jval.2014.08.595.
-
(2014)
Value Health
, vol.17
, pp. A327
-
-
Burnett, H.1
Cope, S.2
Vieira, M.C.3
Sagkriotis, A.4
Senni, M.5
Deschaseaux, C.6
-
79
-
-
0035799381
-
Beta-blockers in congestive heart failure. A Bayesian meta-analysis
-
Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001;134:550-560.
-
(2001)
Ann Intern Med
, vol.134
, pp. 550-560
-
-
Brophy, J.M.1
Joseph, L.2
Rouleau, J.L.3
-
80
-
-
84873350548
-
Benefits of β blockers in patients with heart failure and reduced ejection fraction: Network meta-analysis
-
Chatterjee S, Biondi-Zoccai G, Abbate A, D'Ascenzo F, Castagno D, Van Tassell B, Mukherjee D, Lichstein E. Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ. 2013;346:f55.
-
(2013)
BMJ
, vol.346
, pp. f55
-
-
Chatterjee, S.1
Biondi-Zoccai, G.2
Abbate, A.3
D'Ascenzo, F.4
Castagno, D.5
Van Tassell, B.6
Mukherjee, D.7
Lichstein, E.8
-
81
-
-
84876052291
-
Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: A systematic review and meta-analysis
-
Hu LJ, Chen YQ, Deng SB, Du JL, She Q. Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis. Br J Clin Pharmacol. 2013;75:1202-1212. doi: 10.1111/bcp.12012.
-
(2013)
Br J Clin Pharmacol
, vol.75
, pp. 1202-1212
-
-
Hu, L.J.1
Chen, Y.Q.2
Deng, S.B.3
Du, J.L.4
She, Q.5
-
82
-
-
0037028607
-
Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials
-
Jong P, Demers C, McKelvie RS, Liu PP. Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2002;39:463-470.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 463-470
-
-
Jong, P.1
Demers, C.2
McKelvie, R.S.3
Liu, P.P.4
-
83
-
-
77956322695
-
Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure
-
Kuenzli A, Bucher HC, Anand I, Arutiunov G, Kum LC, McKelvie R, Afzal R, White M, Nordmann AJ. Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS One. 2010;5:e9946. doi: 10.1371/journal.pone.0009946.
-
(2010)
PLoS One
, vol.5
-
-
Kuenzli, A.1
Bucher, H.C.2
Anand, I.3
Arutiunov, G.4
Kum, L.C.5
McKelvie, R.6
Afzal, R.7
White, M.8
Nordmann, A.J.9
-
84
-
-
84989872584
-
Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: A meta-analysis
-
Solomon SD, Claggett B, McMurray JJ, Hernandez AF, Fonarow GC. Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis. Eur J Heart Fail. 2016;18:1238-1243. doi: 10.1002/ejhf.603.
-
(2016)
Eur J Heart Fail
, vol.18
, pp. 1238-1243
-
-
Solomon, S.D.1
Claggett, B.2
McMurray, J.J.3
Hernandez, A.F.4
Fonarow, G.C.5
-
85
-
-
84955465558
-
Renin-angiotensinaldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis
-
Xie W, Zheng F, Song X, Zhong B, Yan L. Renin-angiotensinaldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: network meta-analysis. Int J Cardiol. 2016;205:65-71. doi: 10.1016/j.ijcard.2015.12.010.
-
(2016)
Int J Cardiol
, vol.205
, pp. 65-71
-
-
Xie, W.1
Zheng, F.2
Song, X.3
Zhong, B.4
Yan, L.5
-
86
-
-
84928634952
-
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
-
McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Bělohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R; PARADIGM-HF Committees and Investigators. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J. 2015;36:434-439. doi: 10.1093/eurheartj/ehu455.
-
(2015)
Eur Heart J
, vol.36
, pp. 434-439
-
-
McMurray, J.1
Packer, M.2
Desai, A.3
Gong, J.4
Greenlaw, N.5
Lefkowitz, M.6
Rizkala, A.7
Shi, V.8
Rouleau, J.9
Solomon, S.10
Swedberg, K.11
Zile, M.R.12
Andersen, K.13
Arango, J.L.14
Arnold, M.15
Bělohlávek, J.16
Böhm, M.17
Boytsov, S.18
Burgess, L.19
Cabrera, W.20
Chen, C.H.21
Erglis, A.22
Fu, M.23
Gomez, E.24
Gonzalez, A.25
Hagege, A.A.26
Katova, T.27
Kiatchoosakun, S.28
Kim, K.S.29
Bayram, E.30
Martinez, F.31
Merkely, B.32
Mendoza, I.33
Mosterd, A.34
Negrusz-Kawecka, M.35
Peuhkurinen, K.36
Ramires, F.37
Refsgaard, J.38
Senni, M.39
Sibulo, A.S.40
Silva-Cardoso, J.41
Squire, I.42
Starling, R.C.43
Vinereanu, D.44
Teerlink, J.R.45
Wong, R.46
more..
-
87
-
-
79955660223
-
Network meta-analysis of survival data with fractional polynomials
-
Jansen JP. Network meta-analysis of survival data with fractional polynomials. BMC Med Res Methodol. 2011;11:61. doi: 10.1186/ 1471-2288-11-61.
-
(2011)
BMC Med Res Methodol
, vol.11
, pp. 61
-
-
Jansen, J.P.1
|